Asceneuron SA
Targeting the root cause of neurodegeneration
20 employees · est. 2012 · Lausanne, Switzerland
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
102 employees · est. 2022 · United States
Asceneuron SA is the older company (2012 vs 2022); Rapport Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Asceneuron SA | Rapport Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2012 older | 2022 |
| Headquarters | ||
| Headquarters | Lausanne, Switzerland | United States |
| Employees | ||
| Employees | 20 | 102 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series C | IPO |
| Total Funding | ||
| Total Funding | $130.00M | $654.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Not tracked yet | Discovery of small molecule medicines, Development of CNS disorder treatments, Precision neuroscience research |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with CNS disorders, Healthcare providers, Medical researchers |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Diseases, Biotech Company, Orphan Tauopathies, Alzheimer's Disease, Parkinson's Disease, Small Molecule Therapeutics, O-GlcNAcase Inhibitors, Clinical Stage Development, Neurofibrillary Tangles, Frontotemporal Dementia, Healthcare Innovation, Drug Discovery, Investment Syndicate, Neurological Disorders, Therapeutic Development | Precision Medicine, Neurological Disorders, Neurocircuit Targeting, Receptor-Associated Proteins, Neuromedicines, Drug Discovery, Neuroscience Innovation, Clinical-Stage Biotechnology, Third Rock Ventures, Johnson & Johnson Innovation-JJDC, San Diego Biotech, Boston Biotech, Neurological Drug Development, Teamwork In Biotech, Research And Development |
| Website | ||
| Website | asceneuron.com | rapportrx.com |
About Asceneuron SA
Asceneuron SA is a Switzerland-based clinical stage biotech company with a focus on developing orally bioavailable therapeutics for neurodegenerative disorders. With the mission of targeting the root cause of neurodegeneration, Asceneuron's pipeline aims to address a wide range of neurodegenerative...
About Rapport Therapeutics
Rapport Therapeutics, founded in 2022, is a pioneering company in the Biotechnology, Health Care, and Life Sciences industries. It is based in the United States, specifically in San Diego, CA and Boston, MA. The company is devoted to transforming neurological disorder treatments through precision me...
We will tell you when either one moves
BounceWatch watches Asceneuron SA and Rapport Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Asceneuron SA and Rapport Therapeutics — by email.
Frequently Asked Questions
Compare Asceneuron SA with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Asceneuron SA on 14 Sep 2024, and Rapport Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.